UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023182
Receipt number R000026725
Scientific Title A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neck
Date of disclosure of the study information 2016/08/01
Last modified on 2023/12/27 09:11:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neck

Acronym

Carbon-ion therapy for malignant melanoma of the head and neck (iROCK-1603HN)

Scientific Title

A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neck

Scientific Title:Acronym

Carbon-ion therapy for malignant melanoma of the head and neck (iROCK-1603HN)

Region

Japan


Condition

Condition

mucosal malignant melanoma of the head and neck

Classification by specialty

Oto-rhino-laryngology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of carbon-ion radiotherapy for mucosal malignant melanoma of the head and neck.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

3-year survival rate

Key secondary outcomes

1) Local control rate
2) Disease-specific survival
3) Early and late adverse event rate
4) Local response rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

A total of 64.0 GyE of carbon-ion radiotherapy, consisting of 16 fractions of 4.0 GyE/ day for 6 to 8 times in 2 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Mucosal malignant melanoma of head and neck which is pathologically or cytologically diagnosed
2) Patient without lymph node metastasis (N0) and no remote metastasis(M0)
3) Measurable primary lesion
4) 0 to 2 of performance status
5) 15 years or older and 80 years or younger of age
6)Sufficient organ functions
7) Patient is able to understand this clinical trial and is informed for the diagnosis and disease status. And patient can be given consent with document after explanation of this trial by study personnel

Key exclusion criteria

1)Patient with past history of radiotherapy for the targeted lesion
2)Patient is within 2 weeks after the final chemoterapy
3)Patient with active double cancer

4)Patients with active and intractable infection in the targeted lesion
5) Patient with metal devices in the lesion
6) Other medical or psychological condition which is unsuitable for carbon-ion therapy

Target sample size

65


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Katoh

Organization

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Division name

Department of Carbon-ion Radiotherapy

Zip code

241-8515

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture

TEL

045-520-2222

Email

hkatoh@kcch.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Katoh

Organization

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Division name

Ion-beam Radiation Oncology Center

Zip code

241-8515

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture

TEL

045-520-2222

Homepage URL


Email

hkatoh@kcch.jp


Sponsor or person

Institute

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanagawa Cancer Center IRB

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture

Tel

045-520-2222

Email

clinical_trials@kcch.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神奈川県立がんセンター(神奈川県)


Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2

Results

This study confirmed safety and efficacy comparable to those reported from prior facilities.

Results date posted

2023 Year 12 Month 27 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 03 Month 09 Day

Date of IRB

2016 Year 05 Month 19 Day

Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date

2025 Year 08 Month 31 Day

Date of closure to data entry

2025 Year 08 Month 31 Day

Date trial data considered complete

2025 Year 08 Month 31 Day

Date analysis concluded

2026 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 07 Month 15 Day

Last modified on

2023 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026725


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name